Artelo Biosciences ARTL
NASDAQ ARTL
$3.68 -0.15 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Capital Expenditures (2017 - 2018)

Updated

Artelo Biosciences (ARTL) posted Capital Expenditures of -$188,000 for FY2025.

Analysis

Artelo Biosciences (ARTL) Capital Expenditures (2017 - 2018) Analysis & Trends

  • The FY2025 figure stands as the highest annual Capital Expenditures since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.32 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 322.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -321.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -763.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 140.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 533.00 Mn
10 Artelo Biosciences 73,320.32 -5.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2018 -42.00
Feb 28, 2018 20.00
Nov 30, 2017 867.00
API Access

Artelo Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARTL&period=max&api_key=YOUR_API_KEY